These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 4401352

  • 21. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
    Finn AF, Kaplan AP, Fretwell R, Qu R, Long J.
    J Allergy Clin Immunol; 1999 Nov; 104(5):1071-8. PubMed ID: 10550755
    [Abstract] [Full Text] [Related]

  • 22. Acquired cold urticaria symptoms can be safely prevented by ebastine.
    Magerl M, Schmolke J, Siebenhaar F, Zuberbier T, Metz M, Maurer M.
    Allergy; 2007 Dec; 62(12):1465-8. PubMed ID: 17900265
    [Abstract] [Full Text] [Related]

  • 23. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I, García-Lirio E, Soriano AM, Gamboa PM, Antépara I.
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [Abstract] [Full Text] [Related]

  • 24. Leukotriene modifiers in chronic urticaria.
    Bensch G, Borish L.
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):348. PubMed ID: 10541429
    [No Abstract] [Full Text] [Related]

  • 25. [Treatment of histamine-dependent allergic dermatoses with a 120-mg terfenadine tablet once a day].
    Rigoni C, Cantù A, Toffolo P, Romagnoni G.
    G Ital Dermatol Venereol; 1989 Sep; 124(9):XXXIX-XLI. PubMed ID: 2576823
    [Abstract] [Full Text] [Related]

  • 26. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists.
    Hatakeyama M, Fukunaga A, Washio K, Ogura K, Yamada Y, Horikawa T, Nishigori C.
    J Dermatol Sci; 2016 May; 82(2):137-9. PubMed ID: 26896422
    [No Abstract] [Full Text] [Related]

  • 27. [Therapeutic evaluation of a new antihistaminic: HS-592].
    Guimarães NA, Fonseca O.
    Hospital (Rio J); 1968 Nov; 74(5):1511-4. PubMed ID: 4388711
    [No Abstract] [Full Text] [Related]

  • 28. Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria.
    Ogawa Y, Ichinokawa Y, Hiruma M, Machida Y, Funakushi N, Sadamasa H, Hiruma M.
    J Dermatolog Treat; 2013 Dec; 24(6):463-5. PubMed ID: 23639034
    [Abstract] [Full Text] [Related]

  • 29. Chronic urticaria: review of nonsedating H1 antihistamines in treatment.
    Monroe EW.
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):842-9. PubMed ID: 2903872
    [Abstract] [Full Text] [Related]

  • 30. H1 antagonists in the management of the itch of urticarias.
    Kobza Black A.
    Skin Pharmacol; 1992 Nov; 5(1):21-4. PubMed ID: 1349487
    [Abstract] [Full Text] [Related]

  • 31. SOAP: solutions to often asked problems. Choice of antihistamines for urticaria.
    Alper BS.
    Arch Fam Med; 2000 Aug; 9(8):748-51. PubMed ID: 10927716
    [No Abstract] [Full Text] [Related]

  • 32. Ketotifen and chronic urticaria.
    Taşkapan O, Harmanyeri Y.
    Arch Dermatol; 1998 Feb; 134(2):240-1. PubMed ID: 9487221
    [No Abstract] [Full Text] [Related]

  • 33. Cyproheptadine (Periactin) for allergic and pruritic dermatoses.
    Med Lett Drugs Ther; 1967 Apr 07; 9(7):28. PubMed ID: 4382319
    [No Abstract] [Full Text] [Related]

  • 34. [Tavegil-Sandoz (antihistamicum) in the treatment of several dermatological itching entities].
    Wanic A.
    Pol Tyg Lek; 1968 Oct 07; 23(44):1701-3. PubMed ID: 4387381
    [No Abstract] [Full Text] [Related]

  • 35. [Bilastine [Bellozal), oral].
    Duh D, Tanret I.
    J Pharm Belg; 2012 Dec 07; (4):53-4. PubMed ID: 23350212
    [No Abstract] [Full Text] [Related]

  • 36. [An experimental and clinical investigation concerning the antipruritic effect of pharmaceutical preparations].
    Tronnier H, Schüle D.
    Arztl Forsch; 1968 Jun 10; 22(6):203-12. PubMed ID: 4386944
    [No Abstract] [Full Text] [Related]

  • 37. The clinical efficacy of antihistamines in the skin.
    Tharp MD.
    Allergy; 2000 Jun 10; 55 Suppl 60():11-6. PubMed ID: 10887970
    [No Abstract] [Full Text] [Related]

  • 38. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E.
    Eur J Dermatol; 2007 Jun 10; 17(3):223-8. PubMed ID: 17478385
    [Abstract] [Full Text] [Related]

  • 39. [Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial].
    Eberhartinger C, Ebner H.
    Wien Med Wochenschr; 1969 Sep 20; 119(38):630-2. PubMed ID: 4390510
    [No Abstract] [Full Text] [Related]

  • 40. Clinical inquiries. First- or second-generation antihistamines: which are more effective at controlling pruritus?
    Crownover BK, Jamieson B, Mott TF.
    J Fam Pract; 2004 Sep 20; 53(9):742-4. PubMed ID: 15353166
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.